Cardiovascular risk in Type 2 Diabetes

The risk of CVD mortality in type 2 diabetic patients is more than double compared with that in age-matched subjects. Stroke events and all manifestations of CHD, myocardial infarction (MI), sudden death, and angina pectoris is at least twofold more common in patients with type 2 diabetes than in non-diabetic individuals. A high proportion of patients with type 2 diabetes die after an acute MI within 1 year, and a considerable number of patients die outside the hospital. Relative risk for CHD events is higher in female patients with type 2 diabetes than in male patients with type 2 diabetes. The reason for the sex difference is largely unknown but could be at least in part explained by a heavier risk-factor burden and a greater effect of blood pressure and atherogenic dyslipidemia on the risk of CVD in diabetic women than in diabetic men.

The prognosis of patients with type 2 diabetes is highly dependent on the presence of CVD. We compared the 7-year incidence of fatal and nonfatal MI among 1,373 non-diabetic subjects with the incidence among 1,059 subjects with type 2 diabetes. Our study suggested that patients with type 2 diabetes without previous MI have as high a risk of MI as non-diabetic patients with previous MI. Thus, our results indicated that type 2 diabetes is a “coronary heart disease equivalent.” These results were recently replicated by an 18-year follow-up study of our original cohort and by a Danish study including 3.3 million subjects. One of the paradoxes in the studies of cardiovascular complications in type 2 diabetes is that at diagnosis individuals with type 2 diabetes already has substantially increased prevalence of CHD and stroke.

  • High Blood Pressure
  • Heart Disease
  • High Blood Glucose
  • Damage of Blood Vessels
  • Atherosclerosis and Hypertension
  • Shortness of Breath
  • Diabetic Neuropathy

Related Conference of Cardiovascular risk in Type 2 Diabetes

May 17-18, 2019 |

2ndGlobal Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

Holiday Inn Atrium Singapore |
May 30-31, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
July 29-30, 2019

21st Asia Pacific Diabetes Conference

Sydney, Australia
June 27-28, 2019

18th Global Conference onDiabetes & Nursing Care

Amsterdam, Netherlands
July 05-06, 2019

12th World Congress on Diabetes & Endocrinology

Columbus, USA
July 17-18, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
September 18-19, 2019

12th International Conference on Diabetes & Metabolism

San Francisco | California | USA
September 16-17, 2017

International Conference on Diabetes and Heart diseases

Athens, Greece
September 20-21, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
September 20-21, 2019 |

Euro Diabetes Congress & Expo

Prague, Czech Republic
October 14-15, 2019

Global congress on Endocrinology and Gynecology

Sydney, Australia
October 23-24, 2019

World conference on Diabetes and Heart Congress

Zurich, Switzerland
October 23-24, 2019

Annual Summit on Metabolomics

Amsterdam, Netherlands
October 25-26, 2019 | Radisson Narita |

29th World Diabetes & Heart Congress

Tokyo, Japan
November 25-26, 2019

Global Summit On Diabetes & Endocrinology

Yokohama, Japan
November 29-30,2019

World conference on Diabetes and Endocrine Complications

Barcelona,Spain
December 02-03, 2019 |

14th European Diabetes and Endocrinology Congress

Barcelona, Spain
December 04-05, 2019

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 12-13, 2019

World Congress on Diabetes and Endocrinology

| Dubai, UAE

Cardiovascular risk in Type 2 Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in